Table 4. Economic analyses of cancer new drugs introduced from 1995 to 2014.
Average cost per day on treatment (% of daily GDP per capita) | Average cost per median duration of treatment (% of annual GDP per capita) | |
---|---|---|
1995–1999 | £33.25 (82.6%) | £3037 (20.6%) |
2000–2004 | £49.66 (97.3%) | £7973 (43.4%) |
2005–2009 | £143.70 (233.4%) | £20 233 (89.0%) |
2010–2014 | £160.34 (235.1%) | £35 383 (141.7%) |
Abbreviation: GDP=gross domestic product.
The average of the median cost of treatment with the new agents introduced in each 5-year period is shown as the contemporary actual cost figure and as a percentage of the UK GDP per capita in the first year of listing in the British National Formulary.